10.16.25 -- Clear The Outsourcing Runway: The 8 Largest Deals In The Past Year

Unlock success in next-generation biologics development with Lonza. In this webinar, our experts share real-world case studies and practical CMC strategies to avoid pitfalls, reduce risk, and keep timelines on track. Learn how smart design, cross-functional collaboration, and CDMO partnerships accelerate progress from early development to first-in-human manufacturing—delivering innovative therapies to patients faster. Register now! Click here to learn more.

Understand how formulation development for a prefilled syringe affects manufacturing, driving the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Lyophilization provides stabilization and storage of complex molecules through three main steps: freezing, primary drying, and secondary drying, thereby extending shelf life and increasing availability.

Executing or skipping an engineering run is a consequential decision for any biopharma or CDMO and should be supported by all available data as well as a thorough risk assessment.

The regulatory or political environment can be different for drug development and manufacturing in countries around the globe. Is that a reason to avoid some? Our expert has his doubts.

Outsourcing pharmacovigilance tasks can free up local teams for strategic work. Learn how to build effective partnerships by aligning needs, understanding capabilities, and fostering collaboration.

Orphan drug development is a journey marked by challenges at every step. From patient recruitment to aseptic fill finish, overcoming hurdles is critical for bringing life-saving treatments to market.

Integrating Process Analytical Technology into validated GMP processes for ADC production is complex and costly, requiring thorough validation of equipment and cleaning methods.

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Advanced computational methods coupled with bioinformatics can be used to navigate the complexities of bioprocessing by anticipating challenges before they arise.

Discover a bispecific pairing technology that drives correct heavy-light chain pairing rates in IgG-like bispecifics to >95%. This improves yields of the correct species and streamlines processing.

Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.

Your partner in contract production and development using an end-to-end business model. We specialize in the production of sterile biotechnological products while meeting GMP requirements.

As pressure to accelerate timelines mounts, finding a CDMO committed to increasing capacity and optimizing processes with innovative technologies is key for maintaining high-quality standards.

From early-stage development and clinical trials to full-scale commercial production, our mission is to bring hope to life by enabling life-changing therapies for patients around the world.

To meet industry demands, many turn to temporary staffing — but this model often falls short for long-term needs. Eurofins PSS Insourcing Solutions® (PSS) offers a better alternative.

Successfully implementing PUPSIT requires balancing regulatory compliance with operational efficiency. Gain insights into regulations and expert solutions to help streamline your manufacturing process.